Chang, Hong
He, Guangsheng
Fu, Rong
Li, Fei
Han, Bing
Li, Tao
Liu, Lei
Mittal, Hemant
Jin, Hantao
Zhang, Fengkui
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
https://doi.org/10.1038/s41598-023-45607-0
Article History
Received: 1 June 2023
Accepted: 21 October 2023
First Online: 2 November 2023
Competing interests
: BH, GH, HC, FL, FZ, and RF have no conflicts to declare. HJ and TL are full-time employees of Novartis Pharma Co., Ltd, Beijing, China. LL is a full-time employee of Novartis Pharma Co. and holds Novartis stock options. HM is a full-time employee of Novartis Healthcare Private Limited and holds Novartis stock options. This study was sponsored by Novartis.